Dr. Jennifer N. Davies, MD

Dr. Davies practices at Renaissance Surgery Center - Fresno in Fresno, California.

Dr. Davies' NPI, 1184828238, was assigned on June 13, 2007. Dr. Davies graduated from Keck School of Medicine of USC in 2002. Dr. Davies holds California license A100204.

Dr. Davies' primary practice is Renaissance Surgery Center - Fresno, at 2365 E Fir Ave, Fresno, CA 93720. The practice phone is (559) 974-0885.

Dr. Davies' primary practice is Renaissance Surgery Center - Fresno in Fresno, California. Dr. Davies is also affiliated with Community Regional Medical Center. The medical group on file is Central California ENT Medical Group. Dmand AI also links Dr. Davies to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Davies practices, 7 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Davies' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Davies is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Davies is licensed in California.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Davies treats.

CMS data shows 968 Medicare services from Dr. Davies across 13 procedure codes in 2024, for 487 Medicare patients. Medicare paid $77,864 for them. Every service was in an office.

CMS counts 487 Medicare patients who saw Dr. Davies in 2024. The largest group is 65 to 74, with 208 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Davies' median patient age at 64, with 57% women.

In 2024, Dr. Davies wrote 676 Medicare Part D claims for 205 patients. 90% of them were for generic drugs. CMS names the drug for 553 of them, across 13 drugs with 11 or more claims each, at $136,127 in total drug cost. In 2023, CMS named 420 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Davies for performance year 2024, reported as part of a group. Dr. Davies accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 87 general payments to Dr. Davies from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $602.

Dmand AI lists 1 award for Dr. Davies, most recently CMS Stage 1 EHR in 2014.

Dr. Davies graduated from Keck School of Medicine of USC in 2002.

Dr. Davies is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.